As of 2025-05-14, the Intrinsic Value of Prosus NV (PRX.AS) is 43.41 EUR. This PRX.AS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 45.60 EUR, the upside of Prosus NV is -4.80%.
The range of the Intrinsic Value is 24.68 - 171.45 EUR
Based on its market price of 45.60 EUR and our intrinsic valuation, Prosus NV (PRX.AS) is overvalued by 4.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 24.68 - 171.45 | 43.41 | -4.8% |
| DCF (Growth 10y) | 31.40 - 207.30 | 54.08 | 18.6% |
| DCF (EBITDA 5y) | 11.74 - 21.37 | 16.05 | -64.8% |
| DCF (EBITDA 10y) | 19.60 - 35.14 | 26.11 | -42.7% |
| Fair Value | 72.97 - 72.97 | 72.97 | 60.03% |
| P/E | 45.15 - 78.64 | 53.21 | 16.7% |
| EV/EBITDA | (2.42) - 15.76 | 5.63 | -87.7% |
| EPV | (2.96) - (3.38) | (3.17) | -106.9% |
| DDM - Stable | 31.41 - 184.08 | 107.74 | 136.3% |
| DDM - Multi | 47.12 - 219.35 | 78.10 | 71.3% |
| Market Cap (mil) | 108,480.12 |
| Beta | 1.48 |
| Outstanding shares (mil) | 2,378.95 |
| Enterprise Value (mil) | 114,373.30 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.47% |
| Cost of Debt | 13.37% |
| WACC | 8.20% |